IVP · As filed with the SEC

Inspire Veterinary Partners income statement, by quarter

The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Unaudited Condensed Consolidated Statements of Operations · USD, except per-share amounts

USD, except per-share amounts	Q3 2025^† 3 months ended Sep 30, 2025	Q2 2025 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024	Q4 2023^† 3 months ended Dec 31, 2023
Total revenue	4,316,132	4,283,534	3,639,209	3,321,136^†	4,049,025	3,783,804^†
Service revenue	3,138,670	3,195,266	2,741,029	2,452,941^†	2,969,748	2,670,433^†
Product revenue	1,177,462	1,088,268	898,180	868,195^†	1,079,277	1,113,371^†
Operating expenses
Cost of service revenue	2,678,940	2,435,318	2,139,278	2,030,310^†	2,568,085	2,853,000^†
Cost of product revenue	850,153	871,665	785,409	756,254^†	854,921	788,763^†
General and administrative expenses	2,423,707	2,650,361	2,446,438	3,341,153^†	2,988,122	2,227,037^†
Debt extinguishment loss	0^†	689,411	—	—	0^†	0^†
Beneficial conversion feature	—	—	—	—	—	0^†
Depreciation and amortization	330,498	252,316	275,392	260,329^†	340,167	336,715^†
Gain on sale of business	—	—	—	0^†	(467,049)	—
Total operating expenses	6,283,298	6,899,071	5,646,517	4,856,848^†	6,284,246	6,205,515^†
Loss from operations	(1,967,166)	(2,615,537)	(2,007,308)	(1,535,712)^†	(2,235,221)	(2,421,711)^†
Other income (expenses):
Interest income	4	13	8	7^†	44	3^†
Interest expense	(559,111)	(419,044)	(407,736)	(296,799)^†	(1,254,149)	(793,295)^†
Other income (expenses)	—	—	—	0^†	0^†	(84)^†
Total other expenses	(559,108)	(419,031)	(407,728)	(2,431,010)^†	(1,254,105)	(1,720,430)^†
Loss before income taxes	(2,526,273)	(3,034,568)	(2,415,036)	(3,966,722)^†	(3,489,326)	(4,142,141)^†
Net loss	(2,526,273)	(3,034,568)	(2,415,036)	(3,966,722)^†	(3,489,326)	(4,142,141)^†
Dividend on convertible series A preferred stock	—	—	—	0^†	0^†	(137,417)^†
Net loss attributable to class A and B common stockholders	(2,526,273)	(3,034,568)	—	(3,966,722)^†	(3,489,326)	(4,279,558)^†
Net loss per Class A and B common shares:
Class A and B Common Shares	(0.41)	(0.50)	(0.43)	—	(0.38)	—
Class A and B Common Shares	(0.41)	(0.50)	(0.43)	—	(0.38)	—
Weighted average shares outstanding per Class A and B common shares:
Class A and B Common Shares	6,091,057	6,031,634	5,555,588	—	9,070,371	—
Class A and B Common Shares	6,091,057	6,031,634	5,555,588	—	9,070,371	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.